HIGHLIGHTS
- who: Temi Toba-Oluboka from the (UNIVERSITY) have published the paper: Are the antidepressant effects of insulin-sensitizing medications related to improvements in metabolic markers?, in the Journal: (JOURNAL) of 11/06/2022
- what: Lastly, given the methodological heterogeneity of the included studies, it may be important that this area of research focuses more on producing RCTs.
- how: There were no statistically significant correlations between symptoms and inflammatory markers or insulin resistance (HOMA-IR) in this study even though there was a significant decrease in HOMA-IR with pioglitazone compared to placebo .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.